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Introduction: South Africa has an appreciable burden of both communicable and
non-communicable diseases as well as high maternal, neonatal, and child morbidity.
In recent years there have been significant strides with improving the public health
system, and addressing current inequalities, with the right to health a constitutional
provision in South Africa. Initiatives include the introduction of National Health Insurance,
programmes to enhance access to medicines for patients with chronic diseases, as
well as activities to improve care in hospitals, including improving pharmacovigilance.
Consequently, the objective of this paper is to review ongoing initiatives within the public
healthcare sector in South Africa and their influence to provide future direction.
Method: Principally a structured review of current and planned activities.
Results: There have been a number of major activities and initiatives surrounding
the availability and access to medicines in the public system in recent years in
South Africa. This includes a National Surveillance Centre and an innovative early
warning system for the supply of medicines as well as the development of a National
Health Care Pricing Authority and initiatives to improve contracting. There have
also been developments to improve the supply chain including instigating Medicine
Procurement Units in the provinces and enhancing forecasting capabilities. Access to
medicines is improving though the instigation of stable chronic disease management
initiatives to increase the number of external pick-up points for medicines. There are
also ongoing programmes to enhance adherence to medicines as well as enhance
adherence to the Standard Treatment Guidelines and the Essential Medicines List with
their increasing availability. In addition, there is a movement to enhance the role of
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health technology assessment in future decision making. Hospital initiatives include
increased focus on reducing antimicrobial resistance through instigating stewardship
programmes as well as improving adverse drug reaction reporting and associated
activities.
Conclusion: Overall, there are an appreciable number of ongoing activities within the
public healthcare system in South Africa attempting to ensure and sustain universal
healthcare. It is too early to assess their impact, which will be the subject of future
research.
Keywords: essential medicines, health care reforms, pharmacovigilance, procurement, South Africa, supply chain
INTRODUCTION
South Africa has extended the share of gross domestic product
(GDP) devoted to health over the past two decades. In 1995,
7.42% of GDP was spent on health, whilst currently South Africa
spends 8.5–8.9% of its GDP on health (Department of Health,
2015; Jakovljevic et al., 2017), with pharmaceuticals an estimated
10–15% of this. However, there is a marked inequality to
medicine access in the country, with private healthcare currently
accounting for disproportionate availability of facilities (Table 1).
Increasing income disparities amongst citizens, and growing
out of pocket expenses for healthcare ($67 per capita in 1995
vs. $80 per capita in 2013 adjusted for purchasing price parity),
are challenges to equitable and affordable healthcare for all
(Jakovljevic et al., 2017). As the right to health is a constitutional
provision in South Africa, there has been a strive towards
universal health coverage (UHC) and a unified health system
to improve equitable access to medicines to the population as
a whole (Department of Health, 2012, 2015; Sekhejane, 2013;
Jakovljevic et al., 2017; Perumal-Pillay and Suleman, 2017a,b).
Currently, South Africa is considered the flagship national health
system in sub-Saharan Africa (Jakovljevic et al., 2017), with its
National Department of Health (NDoH) moving towards UHC
with the introduction of the National Health Insurance (NHI)
initiative (Department of Health, 2015; Perumal-Pillay and
Suleman, 2017a). This is likely to continue, certainly in the short
to medium term.
The current population of South Africa is estimated at
55.91 million, 51% female, predominantly young with 30.1%
younger than 15 years and a median age of 25.9 years (Statistics
South Africa, 2016). However, after death rates peaked between
2003 and 2005, this is changing with an upward trend in life
expectancy, mainly attributable to the marked reduction in
mortality from HIV/AIDS with improved treatments and high
adherence rates generally in sub-Saharan Africa (Binagwaho and
Ratnayake, 2009; Ware et al., 2009; Wang et al., 2016a; NDoH,
2017a).
Sub-Saharan Africa still has the highest burden of infectious
disease in the world, with one of four communicable diseases,
HIV/AIDS, malaria, lower respiratory infections, or diarrhoeal
diseases, currently leading causes of years of life lost due to
premature mortality (Lim et al., 2016; Wang et al., 2016a,b;
Fullman et al., 2017). Within sub-Saharan Africa, South Africa
still has one of the highest disease burdens, with a high prevalence
of HIV/AIDS, as well as tuberculosis (TB), resulting in South
Africa being 122nd out of 188 countries in terms of the
Sustainable Development Goals (SDGs) in 2016 (Wang et al.,
2016b; Fullman et al., 2017). It is estimated in South Africa
that 7.03 million patients currently have HIV/AIDS, with a
prevalence rate of 12.7% in 2016, although this can be as high
as 8.4 million (Statistics South Africa, 2016; Wang et al., 2016b).
However, improved access to, and uptake of, antiretroviral (ARV)
treatment, has enabled HIV positive patients in South Africa to
live longer and healthier lives, resulting in a gradual decline in
AIDS-related deaths in recent years (Pillay-van Wyk et al., 2016;
SAMRC, 2016; Wang et al., 2016a; Kabudula et al., 2017).
There is also a high prevalence of sexually transmitted
infections (STIs) among women in South Africa, estimated
at 13%, with an incidence rate of 20 per 100 women years
(Naidoo et al., 2014; Matsitse et al., 2017). Furthermore, there
are increasing concerns with the global growth of antimicrobial
resistance (AMR) similarly in South Africa, including multidrug
resistant bacteria, fungi, HIV, and TB (Paruk et al., 2012). South
Africa has responded through the development of a national
AMR strategy (NDoH, 2015a), which is being put into action
through the national implementation plan (NDoH, 2015b). This
is starting to be addressed through the training of all provincial
health care workers on antimicrobial stewardship practices,
run by two national training centers (Mendelson and Matsoso,
2015; Sooruth et al., 2015; SAASP, 2017), with regional AMR
committees now being established.
There has also been a rise in non-communicable diseases
(NCDs) in South Africa in recent years, similar to other BRIC
countries as well as global trends (Adebolu and Naidoo, 2014;
Jakovljevic and Milovanovic, 2015; Kabudula et al., 2017; NCD
Risk Factor Collaboration (NCD-RisC)—AfricaWorking Group,
2017; Rampamba et al., 2017). Overall, up to 78% of people
aged 50 or over have hypertension in South Africa, resulting
in hypertension being the seventh cause of death and a major
contributor to cardiovascular disease in South Africa (Lloyd-
Sherlock et al., 2014; Statistics South Africa, 2015). In addition,
up to 70% of women and a third of men are currently overweight
or obese in South Africa (Cois and Day, 2015).
Consequently, healthcare in South Africa is faced with major
challenges arising from a high burden of disease including
HIV/AIDS (Wang et al., 2016b), TB, highmaternal, neonatal, and
child morbidity, high levels of trauma and violence, and growing
rates of NCDs (Adebolu and Naidoo, 2014; Naidoo et al., 2014;
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TABLE 1 | An overview of the South African healthcare system (Jobson, 2015; Department of Health, 2016; Econex, 2016; Jakovljevic et al., 2017; Perumal-Pillay and
Suleman, 2017b).
South African Healthcare System
Public Healthcare Private Healthcare
Funding Government Individuals or medical insurance
Hospital capacity ±87,141 beds ±34,600 beds
Population served 82.5–84% (42 million); each public healthcare clinic providing care for on
average 13,718 patients
17.5% (8.2 million)
Expenditure per capita on health in 2013 (current
US$PPP)
US$543 US$578
Total health expenditure (current US$PPP and
million constant 2005US$)
US$28,000 US$31,320
Health information system Mostly paper-based systems; currently changing Electronic based system
Jakovljevic and Milovanovic, 2015; Lalkhen and Mash, 2015;
SAMRC, 2016; Fullman et al., 2017). These challenges have a
profound effect on the health of the South African population,
as the country works toward the goal of universal and equitable
access to healthcare for all citizens (Department of Health, 2015).
The growing burden of NCDs furthermore necessitates health
system reform, moving the focus away from prioritizing acute
care toward managing complex chronic diseases at the primary
health care (PHC) level (Jakovljevic and Milovanovic, 2015).
Initiatives surrounding the NHI build on existing national
medicines policies and the Standard Treatment Guidelines
(STGs) and Essential Medicine List (EML), which have been
implemented in South Africa since 1996 (Gray et al., 2015;
Perumal-Pillay and Suleman, 2016, 2017a,b; Matsitse et al., 2017).
Alongside this, there has been the implementation of
the Central Chronic Medicine Dispensing and Distribution
(CCMDD) programme in South Africa since 2014 to improve
access to chronic medicines and enhance patient experiences
given the increasing prevalence of NCDs (Department of Health,
2015; Department of Health KZN, 2016a; Perumal-Pillay and
Suleman, 2017a). However, there continues to be concern over
the level of education of patients and the subsequent impact
on adherence to the medicines provided (WHO, 2013; Adebolu
and Naidoo, 2014; Nielsen et al., 2017; Rampamba et al., 2017).
It is anticipated that improving adherence rates to treatment
regimens should reduce morbidity and mortality from NCDs
such as cardiovascular diseases (Krousel-Wood et al., 2004;
Calhoun et al., 2008; Nielsen et al., 2017). Patient adherence to
treatment regimens can also be enhanced through improving
patient knowledge and monitoring their care (Moosa et al., 2016;
Nielsen et al., 2017), with ongoing initiatives to address this
including the potential use of diaries and smart phone adherence
applications, given the increasing use of smart phones in South
Africa (Africanews, 2016).
Since 2011, a concerted effort has been made by the
South African NDoH to ensure quality healthcare delivery
at all levels of care, with the publication of the National
Quality Standards for Health, based on seven domains and six
priority National Core Standards (NDoH, 2011). The public
health domain stipulates how health facilities should function
together with local communities and relevant sectors, to promote
health, prevent illness and reduce further complications; and
ensure that integrated and quality care is provided for their
whole community. The patient safety, clinical governance, and
clinical care domains provide quality criteria to ensure quality
nursing, clinical care and ethical practice; reduce unforeseen
harm to healthcare users or patients in identified cases of
greater clinical risk; prevent or manage problems or adverse
events; and support any affected patients or staff (Sekhejane,
2013).
Quality standards are also provided for infection control,
clinical support services andmeasures to enhance the prescribing
of medicines according to treatment guidelines (NDoH, 2011).
In the future, all health facilities must be fully compliant with
national norms and standards to be accredited for providing
services within the NHI. These norms and standards are regularly
updated and are now promulgated as regulations to the National
Health Amendment Act, 2003 (Act No. 61 of 2003) (NDoH,
2017b).
There is growing evidence that access to high-quality
healthcare substantially improves health outcomes for patients
including those with infectious diseases, maternal health, cancers
and NCDs (Barber et al., 2017). Access and quality are important
priorities for UHC, moving towards achieving identified SDGs
(Barber et al., 2017; Fullman et al., 2017). Consequently,
quantifying the extent to which personal healthcare and access
can improve population health, and ultimately health system
performance, is an important priority. However, at this stage,
the SDGs’ UHC target is focused mainly at tracer interventions
in areas of maternal and child health, reproductive health, and
a subset of infectious diseases, without adequately recognizing
the essential role of personal healthcare in combating NCDs
and injuries (Lim et al., 2016; Barber et al., 2017; Fullman
et al., 2017). One way forward is to quantify personal healthcare
access and quality (Barber et al., 2017), with changes in the
Healthcare Access and Quality (HAQ) Index over time indicating
where personal HAQ have improved in parallel with changes in
development. In the case of South Africa, although there has
been a marked improvement in the HAQ Index since 1990,
research shows that greater gains in personal HAQ should still
be possible given South Africa’s place within the development
spectrum (Barber et al., 2017).
Frontiers in Pharmacology | www.frontiersin.org 3 November 2017 | Volume 8 | Article 751
Meyer et al. Ongoing Initiatives in South Africa
Ensuring adequate supplies of medicines, at affordable prices,
is a key element of managing diseases, including NCDs,
effectively. To ensure this, comprehensive procurement systems
and robust supply chain management systems are key to
manage those medicines deemed essential as per the STGs.
Functioning logistic networks will improve access to medicines,
and innovative programmes to assess medication usage will lead
to better understanding of how rationally medication is being
used in a country, as well as ensuring sustainability (Department
of Health, 2012, 2015).
South Africa is continually developing and evaluating
programmes to monitor the care of patients and to assess the use
of medicines in the country, from improving antimicrobial use
(Messina et al., 2015, 2017; Brink et al., 2016), to improving the
functionality of Pharmaceutical and Therapeutics Committees
(PTCs) at all healthcare levels (Gauteng, 2004; Matlala et al.,
2017a), and ongoing pharmacovigilance programmes (Suleman,
2010; Mehta et al., 2014; MCC, 2016; Gauteng, 2017).
Consequently, the objective of this paper is to review ongoing
initiatives within the public healthcare sector in South Africa in
recent years to improve the quality of care, the implications and
influence where known, as well as potential future developments.
As a result, to provide a platform for debating these issues
among key stakeholders in South Africa to help improve future
healthcare delivery efficiently, given the paucity of publications
assessing pharmaceutical policy in developing countries (Gray
and Suleman, 2015).
METHODS
This is principally a structured review of current activities, and
their influence and impact where known, rather than an extensive
literature search of peer-reviewed publications. We have used
similar approaches in previous publications (Dylst et al., 2013;
Godman et al., 2013, 2014; Malmstrom et al., 2013) to provide
a platform for describing and debating key issues to improve
the future quality and efficiency of care, especially regarding
medicines.
FINDINGS
There have been a number of major activities and initiatives
surrounding the availability of, and access to, medicines in the
public system, as well as initiatives to improve patient care and
safety through guidelines, PTCs as well as pharmacovigilance
initiatives, in recent years in South Africa. These initiatives are
expected to continue as part of attaining and maintaining good
quality healthcare for all.
Availability and Supply of Medicines
The medicine value chain plays a critical role in the overall
performance of any health system. Consequently, there is a
need to ensure patients have a dependable supply of the right
medicines, available at the right time, in the right quantity, and
at the right place.
There are a number of innovations that have already been
implemented in South Africa in recent years to improvemedicine
availability and access. A National Surveillance Centre and
FIGURE 1 | Core medicine value chain functions.
innovative early warning system has now been established in
South Africa, with dashboards showing medicine stock levels at
PHC facilities, hospitals and suppliers throughout the country.
This system uses mobile applications, or electronic systems, to
gather information and generate warnings where shortages are
likely to occur.
The NDoH in South Africa has also been piloting and
implementing a number of health system strengthening reforms,
aimed at improving medicine availability and use in recent
years that center on five core medicine value chain functions
(Figure 1), which can be further sub-divided.
The new strategies aim to achieve a continued dependable
supply and reliable payment for goods and services, as well as
improved process efficiencies and governance. These changes
will assist South Africa in servicing the growing patient needs
with the implementation of NHI in a responsive manner. The
overall intention is also to improve the scrutiny over current
medicine prices and their availability with the development
of a National Health Care Pricing Authority, in addition to
proposed changes in supply chain and contracting arrangements.
As a result, address concerns to access and affordability of
medicines, especially essential medicines (Perumal-Pillay and
Suleman, 2017a).
Interventions to Improve Contracting
Most essential medicines in South Africa are sourced through
a centralized, open tendering process where contracts are
entered into between the NDoH and suppliers of medicines,
on behalf of all provinces. With the strategic use of market
intelligence, improved competition and efficiencies associated
with pooled volumes, low prices can be achieved (Pharasi and
Miot, 2012).
Design and implement differentiated contracting
mechanisms
Currently, the majority of pharmaceuticals are contracted
through an open tendering processes in South Africa (Pharasi
and Miot, 2012). This “one-size-fits-all” approach is, however,
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not always suitable. The National Treasury’s 2015 Supply Chain
Management Review Report highlighted the need to implement
“strategic sourcing,” allowing a differentiated approach to
contracting that considers the strategic importance of the product
being purchased, as well as the complexity of the supplier market
(Department National Treasury - Republic of South Africa,
2015). To sustain lowmedicine prices, as well as a reliable supply,
the NDoH in South Africa will be implementing an evidence-
based, differentiated approach to contracting in consultation with
the National Treasury Office of the Chief Procurement Officer
(Department National Treasury - Republic of South Africa,
2015).
Revised contracting mechanisms will also be developed based
on a current review. It is likely that different approaches to
contracting will be established for different medicine “types” to
enhance the availability and affordability of essential medicines.
Implement targeted international and local price
benchmarking to ensure sustained affordability
The use of price benchmarking, similar to other countries
(Leopold et al., 2012), as part of a strategic sourcing strategy will
assist the NDoH in reviewing price trends, including areas of risk
and opportunity. This approach will be adopted as a policy tool
to ensure long-term affordability of pharmaceutical services.
Interventions for Supply Chain Optimization
Currently, the medicine supply chain in South Africa is
characterized by limited planning activities, and outdated
duplicative processes, with high variability among the provinces
and districts. Additionally, storage infrastructure appears ill-
equipped to fully service the growing disease burden and
programme requirements of South Africa. This will change in
the future with a number of planned developments, which are
described below.
Expand functionality of Medicine Procurement Units to
oversee and manage all supply chain functions
Medicine Procurement Units (MPUs) are the cornerstone of
the new supply chain in South Africa, responsible for providing
shared planning and operational management services regardless
of medicine type, point of use, or methods of replenishment and
distribution.
Figure 2 illustrates the visibility of theMPUs. For efficient, co-
ordinated services, MPUs will have full control and visibility for
their given jurisdiction. Networks of MPUs should ultimately be
able to account for all public sector medicine transactions.
The MPUs are responsible for provincial contract
management and monitoring of supply chain performance,
with MPUs now fully implemented with conditions of contract
for every supplier. The accuracy of any forecasting plans will be
monitored by the MPUs, and ultimately at a national level, to
improve future medicine availability and prices.
To guide differentiated approaches to the implementation of
the various reforms and initiatives, a supply chain segmentation
approach has been adopted, coordinated through the MPU.
These supply chain “segments” will now be managed more
efficiently to improve product availability.
Implement collaborative Demand Forecasting and Planning
processes between provinces
Demand Forecasting and Planning (DFP) are the processes used
to estimate patient needs using statistical forecasting techniques.
A Demand Forecast enables the government in South Africa to
mobilize the investments needed to meet the health needs of the
population.
Where medicines have been identified as needed, but have
limited or no availability in South Africa, the Demand Forecast
signals potential sales to the market, and allows suppliers to
plan their investments and business strategies. Collaborative
DFP processes will be established among the provinces in South
Africa, with the national group overseeing its implementation.
Implement supply planning processes
Supply planning initiates responses to identified requirements,
outlined in the Demand Plan, and progresses from the current
situationwhere facilities are typically over, or under, stocked. This
will be overseen by the relevant MPU (Figure 2).
Implement improved inventory management
To adopt effective supply planning, inventory management
must be improved. Processes will include reviewing necessary
minimum infrastructure requirements for storing medicines
appropriately in compliance with legislated norms and standards
for health establishments in South Africa (NDoH, 2011, 2017b),
and ensuring that all health establishments are adequately
resourced to comply with these standards.
Implement improved replenishment management
Currently most public sector healthcare facilities in South Africa
are replenished through a uninformed “pull replenishment
mechanism,” initiated by facility staff equipped with limited
supply chain training. To address concerns with unpredictable
ordering and stock levels, the MPU will provide a shared
planning function for replenishment management, with the aim
of implementing informed push, or advised pull, to improve
medicine supply.
Strengthen distribution planning and differentiated physical
distribution channels
Addressing challenges with inappropriate stock levels and
wastage is growing in importance in South Africa with
the expansion of chronic disease management programmes
(Perumal-Pillay and Suleman, 2017a; Rampamba et al., 2017),
and the implementation of Test and Treat for HIV/AIDS, that
was initiated in September 2016 (Durban, 2016). To address
existing challenges, and expand the capacity of the supply chain,
three distribution channels have been identified:
• Direct delivery
• Central dispensing for patients
• Warehouse distribution
Distribution planning will be introduced by the MPUs to ensure
that distribution processes are optimized across all channels.
Figure 3 illustrates some of the possible combinations of available
channels, all of which will be overseen by the relevant MPU.
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FIGURE 2 | Activities of the Medicine Procurement Unit.
Contracted suppliers will be required to retain specified levels of
finished products to improve cash flow as well as reduce stock
loss and damage. This will result in healthcare facilities having
the peace of mind regarding stock being available and delivered
within contractual lead times. This will be linked to demand and
supply plans as part of an overall contract management function
to improve the distribution system.
In order to further improve the supply chain responsiveness,
and improve access for patients, central dispensing of chronic
medication to an external pick-up point (PuP) convenient
for the patient has already been introduced (Department of
Health, 2015), freeing healthcare workers to attend to patients
who require acute clinical attention (see section Access to
Medicines). Due to improved and easier access to medicines,
patient adherence to treatment should be improved, which will
result in better health outcomes for patients with chronic NCDs.
Interventions for Improved Contract Management
National contracts help leverage economies of scale to achieve
price efficiencies by pooling the demand of all provinces.
Currently, there is fragmentation in contracting due to a
lack of standard processes and systems. A National Contract
Management Unit (CMU) will monitor information aggregated
through MPUs, who will be responsible for implementing
tactical, uniform contract management protocols, as a shared
service on behalf of the health facilities within their jurisdiction.
The shared function between CMU andMPUs is already in place.
However, it is recognized that this development will require agile
institutional processes, capable of responding to the changing
market dynamics to improve future contracting. Processes will
be helped by the fact that the information gathered will be used
to monitor agreed performance metrics, with pertinent changes
implemented to improve future performance if needed.
The relevant MPUs will be responsible for implementing
tactical, uniform contract management protocols, as a shared
service on behalf of the health facilities within their jurisdiction.
Although, there are many interventions that are already
underway, the complexity of the environment means that
there is still a long way to go. Addressing root causes of
current problems over the short, medium and long term, will
require agile institutional processes, capable of responding to the
changing market dynamics that are expected to accompany the
implementation of NHI. The new strategy being implemented
in South Africa aims to achieve a continued dependable supply
and reliable payment for goods and services, improved process
efficiencies and governance, predictable demand and reduced
wastage. These changes will assist South Africa in servicing
the growing patient needs, including those for NCDs, with the
implementation of NHI in a responsive manner.
The overall intention is to improve the scrutiny over the
current prices paid for medicines in South Africa with the
development of a National Health Care Pricing Authority
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FIGURE 3 | Stylized physical distribution channels.
(Department National Treasury - Republic of South Africa,
2015) and a National Health Pricing Advisory Committee, which
will be a ministerial advisory committee (MAC), within the
implementation structures of the NHI (NDoH, 2017c). This is in
addition to ensuring continued access to, and supply of, agreed
medicines.
Surveillance Systems for Medicines
Surveillance systems for medicines include a visibility and
analytics network, which consists of various dashboards
including the assessment of medication availability at PHC and
hospital level, and data triangulation, as well as prescribing data,
guidelines and prices, to improve future medicine procurement
and use.
Supplier performance measurement will be derived from
the South African Pharma Deliveries Data, with performance
scorecards as outputs measuring Lead Time, On Time and In
Full (OTIF) deliveries coupled with timely monthly reporting.
In addition, a Pipeline Analysis Tool (PAT) has been developed
with the data submitted by suppliers on a fortnightly basis. The
visibility of supply vs. demand from suppliers are reported with
forward production planning for at least three months. An Age
Analysis Tool (AAT) has also been developed with the data being
supplied by suppliers giving an indication of outstanding debt
for contracted items. The data will be triangulated with PMPU
stock availability data as well as Hospital and PHC data to add
robustness. This will now provide a proactive response in terms
of stock outs and low stock holding to improve future supplies.
By July 2016, the surveillance systems covered all 3,400 PHC
facilities in South Africa and two thirds of hospitals, with the
initial focus on HIV, TB and vaccines. This is currently being
expanded to other essential medicine items. A key lesson has been
the essential need to establish a master procurement catalog and
bar coding system for nation-wide roll out. Barcodes are seen as
essential to track medicines through the value chain.
Access to Medicines
The changing epidemiological profile of South Africa has
led to an over extension of services delivered by public
sector healthcare facilities, with subsequent enormous strain
on available resources that have contributed towards medicine
shortages and challenges in the quality of care provided.
The Central Chronic Medicines Dispensing and Distribution
(CCMDD) programme was implemented to enhance access to
medicines for stable patients on ARVs, patients on ARVs with
comorbidities as well as patients with NCDs requiring chronic
therapy (Magadzire et al., 2015; Perumal-Pillay and Suleman,
2017a; Rampamba et al., 2017), with its process flows and content
illustrated in Figure 4.
Phases and Outcome from the Implementation of the
CCMDD Programme
The CCMDD programme was initially implemented in ten NHI
districts in February 2014. The Western Cape province was not
included due to the fact that they already had implemented a
similar programme (Magadzire et al., 2015). Due to the success of
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FIGURE 4 | Flow diagram of the Central Chronic Medicines Dispensing and Distribution (CCMDD) process.
the CCMDD programme (Department of Health KZN, 2016b),
it has since been rolled out to 46 districts across the other eight
provinces. Each province has autonomy regarding the conditions
to be managed through the CCMDD programme.
According to service provider reports, more than 1.7 million
patients have been registered on the programme in the eight
provinces. The NDoH has also appointed more than 650 external
PuPs. Additionally, patients can also make use of Adherence
Clubs and outreach PuPs to collect repeat medicines, and these
collection points are managed by the various facilities (see
Figure 3). As a result, access to, and use of, medicines within the
public healthcare sector should appreciably improve.
Available Indicators
Monthly statistics are now available to assist provinces and
government in keeping track of the system and patients to
improve future care. These include the following indicators:
• Number of patients registered per facility/district/province
• Number of districts registered per province
• Number of facilities registered per district/province
• Number of external PuPs appointed per district/province
Additional indicators include the following:
• Number of parcels delivered per PuP or per district/province
• % of patients on ARVs
• % of patients on ARVs with comorbidities
• % of patients with NCDs
• % of patients collecting from external PuPs
An alternative model for structured, safe, and reliable service
delivery closer to a patient’s workplace or home, is the Remote
Automated Dispensing Units (RADUs) (Toit, 2017). However,
only a few of these units are currently being piloted in South
Africa, and it is too early to comment. In terms of future service
delivery, the aim of this type of model is also to create a controlled
method whereby chronic disease patients can, for example,
have screening tests performed when they collect their chronic
medicine parcels (Toit, 2017). This could be an opportunity for
community pharmacies within the private healthcare sector to
introduce an affordable model or service package, which could be
purchased within the NHI system to improve access to medicines
and healthcare (Toit, 2017).
Initiatives to Improve the Quality and
Efficiency of Patient Care
Standard Treatment Guidelines and Essential
Medicine List
The Standard Treatment Guidelines and Essential Medicine List
(STGs-EML) have been developed in South Africa to ensure
medicines are available which are safe, effective, and cost-
effective, and promote the rational use of medicines (Gray et al.,
2015; NDoH, 2015c; Sooruth et al., 2015; Perumal-Pillay and
Suleman, 2016, 2017b). STGs-EML have been developed for all
levels of healthcare, namely PHC (focusing on nurse-initiated
treatment), hospital level guidelines for pediatrics and adults,
and a tertiary/quaternary EML for specialist level (Pharasi and
Miot, 2012), through their respective Expert Review Committees
(ERCs). The ERCs are under the direction of the South African
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National Essential Medicines List Committee (NEMLC), and
consist of key stakeholders relevant for their particular level
of care, such as cardiologists for hospital level and nursing
prescribers for the PHC level (Leong et al., 2015).
Key principles used in the development of the STGs-EML
include evidence-based decision making, with criteria based on
efficacy, safety, affordability, cost-effectiveness, and implications
for practice. Evidence and final medicine selections are peer
reviewed to enhance the robustness of decision making. The
STGs-EML are reviewed by the ERCs on a three-yearly basis, with
two opportunities in the process for South African healthcare
workers to provide comments. Previously published in book
format after the three year review process, completed chapters are
now released on a mobile phone application, the EML Clinical
Guide, allowing health care workers and patients immediate
access to the latest medicines and guidelines in the public
healthcare sector. This mobile application is now the primary
reference source for healthcare workers to access the STGs-EML
(Lancaster, 2016) with the increasing use of smart phones in
South Africa. This is expected to enhance adherence to current
guidelines, which has been variable in practice (Sooruth et al.,
2015; Matsitse et al., 2017).
Recommendations for new medicines to be placed on the
STGs-EML are received by the ERCs from provincial PTCs
within hospitals or from ambulatory care clinics through their
district PTCs. A recent comprehensive publication by Perumal-
Pillay and Suleman documented that in recent years the number
of suggested medicines for PHC facilities within the PHC
STGs-EMLs has increased whilst the number has decreased
for adult and pediatric EMLs (Perumal-Pillay and Suleman,
2016). Comprehensive interviews with key members of the
NEMLC ascertained that the processes have changed over
the years to become predominantly evidence-based (Perumal-
Pillay and Suleman, 2017b). The quality, safety and efficacy of
new medicines for potential inclusion are typically considered
first followed by cost considerations (Perumal-Pillay and
Suleman, 2017b), although affordability is still a major area for
sustainability and access to all.
The development of guidelines with all key stakeholder groups
can include criteria for use as well as criteria restricting the use of
medicines to defined populations, including potential rationing
criteria. The goal of the STGs-EML is enhanced by developing
a well thought out and evidence-based list of key medicines,
which is peer reviewed, to meet the needs of the population,
similar to other countries including Spain, Sweden, and the
United Kingdom (Norman et al., 2009; Gustafsson et al., 2011;
Bjorkhem-Bergman et al., 2013).
Other healthcare systems have faced similar challenges
to South Africa in terms of limited budgets and increased
demand for healthcare (Jakovljevic et al., 2016). This has
resulted in policies to enhance cost-effective prescribing among
Western European countries, including enhancing the use of
generics (Godman et al., 2014), to help maintain universal and
comprehensive healthcare across populations. This is in contrast
to Central and Eastern European (CEE) countries with high co-
payments, with more limited public spending (Jakovljevic et al.,
2016). Such divisions have resulted in for instance appreciably
lower use of biological medicines to treat inflammatory diseases
such as rheumatoid arthritis and inflammatory bowel diseases
among CEE vs. Western European countries (Putrik et al.,
2014a,b; Kostic et al., 2017). The ongoing measures in South
Africa, including chronic disease management programmes
alongside NHI initiatives, should help address concerns seen
among CEE countries.
With the implementation of NHI, the NDoH will be
appointing a MAC on Health Technology Assessment
(HTA). This multi-disciplinary committee will provide
recommendations to the Minister of Health on the prioritization,
selection, distribution, management and introduction of
interventions for health promotion, disease prevention,
diagnosis, treatment, and rehabilitation (NDoH, 2017c). Part of
this will include the creation of a South African HTA Agency
(NDoH, 2017c). The MAC-HTA will be involved in both
investment and disinvestment decisions, similar to agencies in
other countries (Parkinson et al., 2015; Guerra-Junior et al.,
2017).
Integrated Systems Approach to Improve Efficiency
of Access and Care
Improved access to medicines will in future be strengthened
in terms of efficiency by the use of innovative technology to
support the selection of medicines, formulary management,
standard treatment regimens for prescribers, rational medicine
use interventions, and adherence support. An integrated
online platform, Essential Medicines Electronic Access (EMelA),
currently under development will be integrated with various
electronic platforms, including electronic prescribing and
dispensing tools, patient management systems and stock
management systems (Figure 5).
Alongside these changes, there will be ongoing programmes
to enhance compliance to the STGs. This includes possibly
educational and other activities including pharmacists and other
key stakeholders where there are concerns with prescribing,
which is likely to include academic detailing similar to other
countries (Costa et al., 2016). Ongoing research programmes
will include seeking ways to further improve compliance
to prescribing guidance to improve future care where there
are identified concerns (Sooruth et al., 2015; Matsitse et al.,
2017). Instigation of electronic prescribing and monitoring of
prescriptions against agreed guidance will also enhance future
adherence to prescribing guidance, as seen for instance with the
“Wise List” in Stockholm County Council in Sweden (Gustafsson
et al., 2011; Bjorkhem-Bergman et al., 2013; Eriksen et al.,
2017).
Programmes to Improve Adherence and Retention in
Care
With growing numbers of patients accessing treatment for HIV,
TB, and NCDs, adherence increasingly becomes a challenge
for all patients with chronic diseases (Rampamba et al.,
2017). Despite South Africa having the largest ARV treatment
programme in the world, with generally better adherence rates in
sub-Saharan Africa compared with North America (Binagwaho
and Ratnayake, 2009), challenges such as declining retention in
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FIGURE 5 | Integrated systems approach to improve efficiency of access to medicines.
care rates, and increased drug resistance due to poor adherence
among some patients and poor programme performance are
evident (Awolola et al., 2014; Baloyi et al., 2014; Ramdas et al.,
2015; Vagiri et al., 2015).
To address these concerns, the South African NDoH
recently introduced their National Adherence Guidelines for
Chronic Diseases including HIV, TB, and NCDs to enhance
treatment adherence, working towards Vision 2030 of the
National Development Plan (Republic of South Africa, 2012;
NDoH, 2016). These guidelines aim to strengthen access to
appropriate services in order to improve clinical outcomes,
and for people with chronic diseases ensure linkage to care,
retention in care, and support, to enhance their adherence to
treatment (NDoH, 2016), with enhanced adherence improving
outcomes (Ho et al., 2009; Corrao et al., 2011; Abegaz et al.,
2017).
Overall, the aim is to introduce a minimum package of
interventions to ultimately support linkage to care, adherence
and retention in care, to improve future patient outcomes. This
includes standardized education counseling on hypertension,
diabetes, TB and HIV, including child and adolescent disclosure
counseling. In addition, alternative repeat prescription collection
strategy options (see section Access to Medicines), early tracing
and retention in care as well as integrated management of
chronic conditions involving multi-disciplinary groups. This
will include patient adherence plans and pamphlets, adherence
information, training files, standard operating procedures, fast
track initiation counseling, and the setting of treatment goals
(Toit, 2017).
Antimicrobial Stewardship Programmes
There are ongoing programmes within hospitals in South Africa
to instigate antimicrobial stewardship programmes (ASPs) to
reduce AMR (Brink et al., 2016; SAASP, 2017), which is
a growing problem worldwide (WHO, 2014, 2015; Hoffman
and Outterson, 2015; Mendelson and Matsoso, 2015; NDoH,
2015a,b). Antimicrobial stewardship refers to coordinated
interventions designed to improve and monitor the appropriate
use of antibiotics by promoting the selection of the optimal
antibiotic agent(s), dose, duration of therapy, and route of
administration. The large burden of infectious diseases in South
Africa has necessitated the following specific antimicrobial
stewardship goals: optimizing therapy for individual patients,
preventing overuse andmisuse of antibiotics, andminimizing the
development of resistance at patient and community health levels
(NDoH, 2015a,b).
This increasingly includes utilizing existing resources of
pharmacists, registered nurses and other healthcare programmes
to co-ordinate anti-infective management programmes and
subsequently improve patient outcomes (Schellack et al.,
2016; Goff and Mendelson, 2017). Major shifts in policy
toward combatting AMR within the South African healthcare
environment culminated in the NDoH’s publication of
South Africa’s Antimicrobial Resistance National Strategy
Framework 2014-24, published in October 2014 at a Ministerial
Antimicrobial Resistance Summit to retain the effectiveness of
available antibiotics (NDoH, 2015a) This is a multidisciplinary,
intersectoral strategy combining human health, animal health,
and environmental health sectors, which is implemented
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through the MAC on AMR. One of the strategic objectives of the
framework was to “promote appropriate use of antimicrobials
in human and animal health” through ensuring access to
safe, effective and affordable antimicrobials, institutionalizing
ASPs across sectors, and addressing the use of antimicrobials
in animal health and crop production. This Committee is
currently developing a series of guidance documents regarding
the governance structures necessary at each level of care, the
monitoring of antimicrobial use and resistance at the healthcare
level, and the appropriate use of antimicrobials at all healthcare
levels, in human and animal health (NDoH, 2015a,b).
Parallel to this, and as part of the country’s drive towards
quality healthcare service delivery, specific antimicrobial
stewardship, and infection prevention control norms and
standards were finalized and published for public comment
in the Government Gazette, with a view to becoming
enforceable regulations in the future. The terms of reference
of provincial AMR committees have been developed, and
these committees are currently in the process of being
established.
The need for pharmacist-led ASPs was demonstrated in a
recent study with analysis of 47 private hospitals across South
Africa revealing that close to one in every 15 prescriptions
contained inappropriately prescribed antibiotics, requiring an
intervention. The study highlighted the role pharmacists can
play to improve future antibiotic use in South Africa as
infectious disease-trained specialists are currently limited in
number (NDoH, 2015a,b; Brink et al., 2016). Research is also
being undertaken in public hospitals to assess the situation
in this important sector (Schellack et al., 2017; Bester et al.,
in press).
Furthermore, the Committee is currently developing
a national AMR and antibiotic use national surveillance
dashboard, which includes private and public healthcare sector
data. The South African Society of Clinical Pharmacy has also
developed a guideline to outline the importance, role and
purpose of pharmacists in ASPs within South African hospitals
to improve the use of antimicrobials. This is in addition to other
strategies as part of the South African government’s national
strategy initiative to reduce AMR (NDoH, 2015a,b).
Pharmaceutical and Therapeutics Committees
It is also recognized that the role and functionality of PTCs
needs to improve within the health system, at provincial,
district, and institutional levels, in South Africa to enhance
appropriate medication procurement and usage decisions to
ensure sustainable financial practices that will improve patient
care following the instigation of the National Drug Policy in 1996
(NDoH, 1996; Gray et al., 2015). In light of this, the National
Policy for the Establishment and Functioning of Pharmaceutical
and Therapeutics Committees in South Africa was published
in 2015 (NDoH, 2015d). A guidance document with clearer
directives on the functioning of the PTC is currently under
development. PTC activities typically include dissemination of
decisions from the NEMLC meetings as well as any formulary
management changes at their respective healthcare institutions.
However, there are concerns with the level of reporting
of adverse drug reactions (ADRs) and medication errors, as
well as lack of evidence-based decision-making in formulary
management (Suleman, 2010; Matlala et al., 2017a,b; Truter
et al., 2017). This follows research highlighting the lack of
reporting of ADRs within hospitals in South Africa, exacerbated
by lack of knowledge of the processes involved (Matlala et al.,
2017a; Terblanche et al., 2017a). This is perhaps not surprising
with published research highlighting in South Africa that ADRs
frequently develop whilst patients are in hospital (Mehta, 2011;
Terblanche et al., 2017a). In addition, in a study conducted
among four adult medical wards in South Africa, the authors
estimated that ADRs contributed to the death of 2.9% of admitted
patients (Mouton et al., 2015). The overall mortality rate was 18
per 100 admissions, with 16% of deaths ADR-related (Mouton
et al., 2015). These factors have resulted in concerns regarding
the current extent of pharmacovigilance activities in South
Africa. However, recent studies among South African teaching
and secondary hospitals have shown the benefit of pharmacists’
interventions making it easier to detect adverse events, and to
classify harm to a particular adverse event, to improve reporting
rates and subsequent patient care (Müller et al., 2016; Terblanche
et al., 2017b).
Pharmacovigilance and Patient Safety
Previously, pharmacovigilance has been seen as a relatively new
science in Africa (Ampadu et al., 2016). This has changed
with an appreciable number of African countries now part of
WHO Programmes for Drug Monitoring including South Africa
(Ampadu et al., 2016). Pharmacovigilance (PV) activities in
South Africa have been helped by the formation of a national
PV Working Group within the Medicines Control Council
(MCC) of South Africa dedicated to this (MCC, 2017), providing
direction (MCC, 2012). There have also been regional initiatives
to further improve PV and the reporting of ADRs (Gauteng,
2017).
However, despite these initiatives, most healthcare
professionals in public sector hospitals in South Africa
seem unaware of ADR reporting systems, with only a very
limited number of professionals receiving training on ADR
reporting, with the vast majority indicating the need for
such training (Terblanche et al., 2017a). Following the recent
introduction of a pharmacist-driven PV system within a
public sector hospital in South Africa, the vast majority of
healthcare professionals now support the system (97%), with
85% understanding the need for ADR-reporting. This is
helped by 69% now knowing there are ADR forms available
(up from 15.2%), with 73% now knowing to whom ADR
reports should be submitted (up from 19%). Reasons for non-
reporting of ADRs also decreased significantly (Terblanche et al.,
2017b).
To further increase access to appropriate reporting channels,
access to the national ADR reporting forms are now available on
the EML Clinical Guide mobile application. Reports submitted
on this application are received by the NDoH Pharmacovigilance
Centre for Public Health Programmes and forwarded to the
MCC. It is hoped this innovation will also increase ADR
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reporting as the use of smart phones continues to increase in
South Africa.
A pharmacist’s participation in the management of hospital
in-patients on ARV treatment through the provision of
pharmaceutical care has also proven to be beneficial for the
identification, management and reporting of ADRs (Ally et al.,
2015). This kind of research, and the implications for future
activities to reduce the extent of ADRs, and their implications on
patient morbidity, mortality and costs, will also be undertaken
among public hospitals in South Africa to improve future
patient care.
DISCUSSION AND CONCLUSIONS
There are an appreciable number of ongoing activities within
the public healthcare system in South Africa to ensure equitable
access to medicines and to improve the care of patients. This
follows the instigation of universal access for all patients in
South Africa, along with recognition of the growing burden
of NCDs in South Africa. Appreciable strides have already
been made in reducing the costs of medicines used in the
public healthcare sector, particularly ARV treatment for HIV
infection.
South Africa has already made some progress towards the
SDGs as is evident from an analysis of the health-related SDG
indicators based on the Global Burden of Disease studies (Lim
et al., 2016; Fullman et al., 2017). Although South Africa’s health-
related SDG index was below the median for 188 countries (46 vs.
59.3 in 2015 and 122nd out of 188 countries in 2016) (Lim et al.,
2016; Fullman et al., 2017), progress has been seen for indicators
such as the UHC tracer with a SDG index of 79, similar to
the multi-country median. However, still below the UHC tracer
target of 100% by 2030 (Lim et al., 2016). Low performance
for indicators such as NCDs, childhood obesity, harmful alcohol
use, and mortality due to self-harm and interpersonal violence,
suggest further interventions are still needed to improve the care
of patients in the public healthcare system (Lim et al., 2016;
Fullman et al., 2017).
In terms of future estimation of the SDG indicators though,
as well as evaluating the influence of future interventions, one
should recognize the data gaps with these indicators (Lim et al.,
2016). For the UHC tracer indicator, a set of tracer interventions
are restricted to reproductive, maternal and child health, as well
as a subset of infectious diseases. Furthermore, data on the
coverage of NCD interventions and high-level care are limited,
as the UHC tracer indicator only captures the interventions
used and not the quality of the interventions provided. Future
revisions are subsequently required as additional data becomes
available on the delivery of interventions to improve the
management of NCDs in South Africa, including the chronic
disease management programmes as well as the modification of
risk factors, with improved management of NCDs a key priority
area in South Africa.
Ongoing programmes to improve care in South Africa include
the management of chronic diseases incorporating the STGs-
EML along with programmes to make access to medicines easier
for patients such as the CCMDD programme. In addition,
programmes and activities to improve the supply chain as
well as continue to obtain essential medicines at low prices.
The instigation of central procurement practices ensures the
department leverages economies of scale to help to a large
extent to procure medicines at optimum prices. There are also
ongoing programmes within public hospitals in South Africa
to improve the quality of care as well as reduce current AMR
and ADR rates. Reducing AMR rates is critical with increasing
use of antibiotics, with utilization increasing globally by 36%
between 2000 and 2010, with countries such as China, India,
and South Africa accounting for 76% of this increase (O’Neill,
2015). Increasing AMR rates pose a serious public health threat
as well as increasing costs (Gandra et al., 2014; Hoffman and
Outterson, 2015; O’Neill, 2015). In the South African context,
especially in the public sector, it is difficult to replicate resource-
abundant ASP models. Sustainable and effective ASPs largely
depend on monitoring practices, teamwork in developing and
implementing interventions, and organizational infrastructure.
Consequently, it is critical in the South African context to
utilize existing resources such as pharmacists, registered nurses,
and other members of the healthcare team, to drive forward
ASPs, which is already happening (SAASP, 2017). For effective
ASPs in South Africa, it is important to recognize the skills
within multidisciplinary teams that can support pharmacists to
improve antibiotic prescribing practices within the South African
Antimicrobial Resistance National Strategy Framework and its
implementation (NDoH, 2015a,b). These are considerations for
the future. Potential research activities in the community include
a better understanding of key stakeholder attitudes to AMR, and
how to develop programmes relevant to their needs, to improve
future antibiotic prescribing and dispensing.
HTA will also play an increasingly important role in decision
making in South Africa in the future to help assess which future
technologies to invest in and which technologies to disinvest in.
This will be closely monitored.
Future monitoring of UHC progress in South Africa should
combine the HAQ Index, coverage of health interventions,
and prevalence of risk factors that can be modified through
public health initiatives (Barber et al., 2017). This will provide
a more comprehensive measure of the capacity of South Africa’s
healthcare system capacity to ensure personal HAQ.
Technology will also play a more prominent and important
role in the future in South Africa to improve access and
availability of medicines, and reduce wastage. As mentioned,
a National Surveillance Centre and innovative early warning
system has been established, with dashboards showing medicine
stock levels at various levels of care throughout the country.
Mobile applications or electronic systems are being used to
collect information and to alert of possible medicine shortages.
Innovative technology is also being used to empower health
care workers to provide quality services. The STGs-EML are
available as a mobile application, which also allows reporting
of ADRs, reporting of stock-outs and provision of information
about healthcare facilities. There are also ongoing programmes
to improve the management of patients with NCDs, including
their education and monitoring of adherence to medicines
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(Rampamba et al., 2017). In addition, the NDoH will continue
to interrogate innovative technologies to improve service
delivery and the quality of care. This potentially includes
how mobile applications can be used to enhance medicine
adherence especially in environments with limited health literacy.
Other research programmes include a better understanding of
facilitators and barriers to medicine adherence. Consideration
of the role of social capital also needs to be better understood
in South Africa building on previous research (Binagwaho and
Ratnayake, 2009; Ware et al., 2009).
To date, there have been limited formal evaluations of
the impact of the extensive number of recent initiatives in
South Africa. This is changing, and will be part of future
research projects to further improve the quality and efficiency
of prescribing in South Africa as the country strives to develop
and maintain UHC in the face of an appreciable burden of
both infectious and NCDs. Social determinants of health, and
the causes of ill health, also need to be investigated further in
South Africa with factors such as the level of education and
medicine use knowledge substantially impacting on lifestyles and
adherence to medicines (Moosa et al., 2015; Rampamba et al.,
2017).
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